-
Board Certification
American Board of Obstetrics & GynecologyAmerican Board of Obstetrics & Gynecology (Sub: Gynecologic Oncology)Patient Rating
4.9 /5( out of 88 reviews )The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.
The scale on which responses are measured is 1 to 5 with 5 being the best score.
Patient Comments
Patient comments are gathered from our patient experience survey and displayed in their entirety.
Patients are de-identified for confidentiality and patient privacy.September 24, 2024HUNTSMAN CANCER CENTERDr. Maurer is very knowledgeable, very kind, and attentive. Her personality is contagious. I truly loved her as my surgeon.
September 24, 2024HUNTSMAN CANCER CENTERShe cares about you as a person. She spends time. She explains and listens.
September 11, 2024HUNTSMAN CANCER CENTERWould recommend Dr Maurer and her Team to anyone. Very caring and willing to explain and answer all questions
July 30, 2024HUNTSMAN CANCER CENTERDr Maurer is knowledgeable but conveys her clinical assessments of each patient in the most genuine and personable manner. She has a wonderful "bedside manner" and welcomes questions.
July 19, 2024HUNTSMAN CANCER CENTERShe is an amazing Dr. I had a complete total hysterectomy with a couple nodes removed. From when we first met she explained my cancer to me and answered any questions I had. I just passed my 4 year cancer free. I enjoy seeing her every year. She is definitely a favorite Dr of mine and I would highly recommend her to anyone!!
July 18, 2024HUNTSMAN CANCER CENTERDr Maurer makes you feel as if you were her only patient! She makes direct eye contact, listens to your concerns, answers a question (no matter how many you have) & takes your ideas in treatment planning options into consideration. Dr Maurer is upbeat, knowledgeable and professional without being overly clinical. I consider myself very fortunate to have such a well-respected & accomplished individual to be my oncology doctor!
July 17, 2024HUNTSMAN CANCER CENTERExcellent bedside manner and instills great trust.
July 09, 2024HUNTSMAN CANCER CENTERWas really good in professional in everything
July 02, 2024HUNTSMAN CANCER CENTERExcelente persona y profesional
-
Board Certification and Academic Information
Academic Departments Obstetrics & Gynecology -Primary Academic Divisions Gynecological Oncology
Board Certification American Board of Obstetrics & GynecologyAmerican Board of Obstetrics & Gynecology (Sub: Gynecologic Oncology)Education history
Fellowship Gynecologic Oncology - Cleveland Clinic Fellow Obstetrics and Gynecology - ÈËÆÞÖгöÊÓƵ of Utah School of Medicine Resident Professional Medical Medicine - ÈËÆÞÖгöÊÓƵ of Michigan Medical School M.D. Geology, Biology - Brown ÈËÆÞÖгöÊÓƵ Sc.B. Selected Publications
Journal Article
- Barnard ME, Farland LV, Yan B, Wang J, Trabert B, Doherty JA, Meeks HD, Madsen M, Guinto E, Collin LJ, Maurer KA, Page JM, Kiser AC, Varner MW, Allen-Brady K, Pollack AZ, Peterson KR, Peterson CM, Schliep KC (2025). Endometriosis Typology and Ovarian Cancer Risk. JAMA, 332(6), 482-489. ()
- Scaglione MA, Allshouse AA, Canfield DR, Mclaughlin HD, Bruno AM, Hammad IA, Branch DW, Maurer KA, Dood RL, Debbink MP, Silver RM, Einerson BD (2022). Prophylactic Ureteral Stent Placement and Urinary Injury During Hysterectomy for Placenta Accreta Spectrum. Obstet Gynecol, 140(5), 806-811. ()
- Straubhar AM, Parsons MW, Francis S, Gaffney D, Maurer KA (2021). Refusal of surgery and survival outcomes in endometrial cancer. Int J Gynecol Cancer, 31(9), 1236-1241. ()
- Casper AC, Parsons MW, Chipman J, Burt LM Jr, Suneja G, Maurer KA, Gaffney DK (2021). Risk of secondary malignancies in ovarian cancer survivors: 52,680 patients analyzed with over 40 years of follow-up. Gynecol Oncol, 162(2), 454-460. ()
- Parsons MW, Francis S, Maurer KA, Grant J, Gaffney DK (2020). Refusal of Radiation Results in Inferior Survival in Endometrial Cancer. Am J Clin Oncol, 43(6), 399-410. ()
- Harris KL, Maurer KA, Jarboe E, Werner TL, Gaffney D (2019). LVSI positive and NX in early endometrial cancer: Surgical restaging (and no further treatment if N0), or adjuvant ERT? Gynecol Oncol, 156(1), 243-250. ()
- McComas KN, Torgeson AM, Ager BJ, Hellekson C, Burt LM, Maurer KA, Werner TL, Gaffney DK (2019). The variable impact of positive lymph nodes in cervical cancer: Implications of the new FIGO staging system. Gynecol Oncol, 156(1), 85-92. ()
- Rodriguez AC, Blanchard Z, Maurer KA, Gertz J (2019). Estrogen Signaling in Endometrial Cancer: a Key Oncogenic Pathway with Several Open Questions. Horm Cancer, 10(2-3), 51-63. ()
- Gaffney DK, Hashibe M, Kepka D, Maurer KA, Werner TL (2018). Too many women are dying from cervix cancer: Problems and solutions. Gynecol Oncol, 151(3), 547-554. ()
- Maurer K, Michener C, Mahdi H, Rose PG (2016). Universal tolerance of nab-paclitaxel for gynecologic malignancies in patients with prior taxane hypersensitivity reactions. J Gynecol Oncol, 28(4), e38. ()
Case Report
- Wei M, Maurer KA, Henry NL (2019). Ovarian remnant syndrome in an aromatase inhibitor-treated patient with BRCA2 mutation following bilateral oophorectomy. Breast J, 25(6), 1254-1256. ()